About EDITCO BIO INC
EditCo is a biotechnology company specializing in cell engineering, offering CRISPR-based gene editing services and products for research in oncology, immunology, genetic disease, and other fields.
CRISPR gene knockout and knock-in servicesDevelopment of immortalized, iPSC, and primary cell linesEndogenous protein tagging with HiBiT, NanoLuc, and HaloTagHigh-throughput cell editing platformsCustom-engineered cell lines for disease modeling and research
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| HIBIT-TAGGED FLT3 CELL LINE | Department of Health and Human Services | $15K | |
| 24-016468 DR. MARTINA REQUIRES KNOCK-IN CELL LINE GENERATION SERVICES IN ORDER TO PERFORM CELL BIOLOGY EXPERIM | Department of Health and Human Services | $11K | |
| SYNTHEGO:1293873 [24-007185] | Department of Health and Human Services | $35K | |
| 2 SFRP1-HIBIT-TAGGED CELL LINES FOR SMALL MOLECULE SCREENING | Department of Health and Human Services | $24K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to EDITCO BIO INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.